Model-based Investigation of Cyp3a Enzyme Inactivation Effect of Risdiplam in Infants, Children, and Adults with Spinal Muscular Atrophy (sma).

Y Cleary; M Gertz; P Grimsey; A Guenther; K Heinig; K Ogungbenro; L Aarons; A Galetin; H Kletzl

doi:10.1002/cpt.2167

Model-based Investigation of Cyp3a Enzyme Inactivation Effect of Risdiplam in Infants, Children, and Adults with Spinal Muscular Atrophy (sma).

Y Cleary
, M Gertz
, P Grimsey
, A Guenther
, K Heinig
, K Ogungbenro
, L Aarons
, A Galetin
, H Kletzl

Pharmacy

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S9-S10
Number of pages	2
Journal	Clinical Pharmacology & Therapeutics
Volume	109
Issue number	S1
DOIs	https://doi.org/10.1002/cpt.2167
Publication status	Published - Mar 2021

Access to Document

10.1002/cpt.2167

Cite this

@article{e916486a4fb943ca81df493eb3a1b2b9,

title = "Model-based Investigation of Cyp3a Enzyme Inactivation Effect of Risdiplam in Infants, Children, and Adults with Spinal Muscular Atrophy (sma).",

author = "Y Cleary and M Gertz and P Grimsey and A Guenther and K Heinig and K Ogungbenro and L Aarons and A Galetin and H Kletzl",

year = "2021",

month = mar,

doi = "10.1002/cpt.2167",

language = "English",

volume = "109",

pages = "S9--S10",

journal = "Clinical Pharmacology \& Therapeutics",

issn = "0009-9236",

publisher = "John Wiley \& Sons Ltd",

number = "S1",

}

TY - JOUR

T1 - Model-based Investigation of Cyp3a Enzyme Inactivation Effect of Risdiplam in Infants, Children, and Adults with Spinal Muscular Atrophy (sma).

AU - Cleary, Y

AU - Gertz, M

AU - Grimsey, P

AU - Guenther, A

AU - Heinig, K

AU - Ogungbenro, K

AU - Aarons, L

AU - Galetin, A

AU - Kletzl, H

PY - 2021/3

Y1 - 2021/3

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000619875100018&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1002/cpt.2167

DO - 10.1002/cpt.2167

M3 - Meeting Abstract

SN - 0009-9236

VL - 109

SP - S9-S10

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

IS - S1

ER -

Model-based Investigation of Cyp3a Enzyme Inactivation Effect of Risdiplam in Infants, Children, and Adults with Spinal Muscular Atrophy (sma).

Access to Document

Other files and links

Cite this